메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

GROWNSY Wraps Up October Prime Day with Strong Performance, Reinforcing Its Commitment to Smart Parenting

NEW YORK, Oct. 15, 2025 -- GROWNSY, a fast-growing baby care brand trusted by parents across the U.S., concluded Amazon's October Prime Day with strong performance and outstanding recognition across key baby product categories. Three of its flagship products—Baby Nasal Aspirator, Baby Bottle Warmer with Timer, and Baby Food Maker—earned Amazon Best Seller badges in their respective categories:#1 in Baby Nasal Aspirators, #2 in Bottle Warmers, and #1 in Baby Food Mills. These achievements highlight GROWNSY's growing influence among parents who seek practical, safe, and intelligently des
- 김갑성 기자
- 2025-10-15 21:00
TriNetX Becomes the Most Cited Real-World Data Source in Peer-Reviewed Research

With more than 2,000 citations and year-over-year growth nearing 80%, TriNetX outpaces competitors and fuels high-impact science published in top medical journals. CAMBRIDGE, Mass., Oct. 15, 2025 -- TriNetX, driven by its vision of a connected world where data and intelligence power improved human health, has become the most cited electronic health record dataset in peer-reviewed publications, according to a recent analysis of PubMed data through August 27, 2025. The findings highlight a sharp rise in the use of TriNetX data by clinical researchers, public health agenci
- 김갑성 기자
- 2025-10-15 20:34
SK bioscience Files for First-in-Human Trial of Universal Coronavirus Vaccine (Pan-sarbecovirus Vaccine) GBP511 Phase 1/2 study in Australia

Candidate designed to protect against COVID-19 variants and broader Sarbecoviruses Phase 1/2 study to enroll ~500 healthy adults, with topline results expected by 2028 We aim to build a universal Sarbecovirus vaccine platform to proactively address future pandemics SEONGNAM, South Korea, Oct. 15, 2025 -- SK bioscience announced that it has submitted a Phase 1/2 clinical trial application in Australia for GBP511, a universal coronavirus vaccine (pan-sarbecovirus vaccine) candidate. Sarbecoviruses, a subgenus of coronaviruses, include SARS-CoV-2 (COVID-19)
- 김갑성 기자
- 2025-10-15 20:00
International Biopharma Industry Week Shanghai 2025 Kicks Off -- Building a Global Magnet for Full-Chain Biopharmaceutical Innovation

SHANGHAI, Oct. 15, 2025 -- On October 13, the opening ceremony of the International Biopharma Industry Week Shanghai 2025（IBIWS 2025）was held at the Zhangjiang Science Hall. The event is hosted by the Shanghai Center of Biomedicine Development and organized by Shanghai Biological Medicine Public Technology Service Co., Ltd. and Shanghai Yicai Wanxiang Information Technology Co., Ltd. IBIWS 2025, in the theme of "Global Linkage, Industrial Empowerment", will last from October 13 to 17, during which a series of activities will be organized, including thematic forums, ac
- 김갑성 기자
- 2025-10-15 19:49
Ispire Technology Inc. to Participate in Upcoming October Conferences

LOS ANGELES, Oct. 15, 2025 -- Ispire Technology Inc. (NASDAQ: ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today announced that Ispire Technology Inc.'s management team is scheduled to participate in the following October 2025 investor conferences. LD Micro's 19th Annual Main EventDate: October 19-21, 2025Presentation Date & Time: Tuesday, October 21, 2025, at 3:00 p.m. PTLocation: Hotel Del Coronado, San DiegoWebcast: https://ldmicrocasts.com/#register
- 김갑성 기자
- 2025-10-15 19:00
First Key Update of the International AI Safety Report released

MONTREAL, Oct. 15, 2025 -- The first Key Update of the International AI Safety Report has been published, providing a timely update on the capabilities and risks of advanced AI. Chaired by Turing Award-winning computer scientist Yoshua Bengio, the Report involves more than 100 international experts and is backed by over 30 countries and international organisations including the EU, OECD and UN. Recognising that the field is evolving too quickly for a single annual report, Key Updates have been introduced to provide shorter, focused reports on critical developments. This will ens
- 김갑성 기자
- 2025-10-15 19:00
Tamarind Health Marks Next Phase as Asia's Leading Integrated Oncology Platform

SINGAPORE, Oct. 15, 2025 -- Tamarind Health marks the next phase in its growth as Asia's leading integrated oncology-focused healthcare platform, following the completion of its acquisition of TalkMED in September 2025. A doctor-led platform built on the principle of putting patients first, Tamarind Health brings together leading medical practices across the region under a single umbrella. The platform reflects the shared vision of renowned specialists, beginning with the founding doctors of OncoCare Singapore, Dr Miah Hiang Tay and Dr Peter Ang. Their practice ha
- 김갑성 기자
- 2025-10-15 17:01
인도 최고 대학 IIT 마드라스, 현대자동차 인도법인과 소아암 치료 혁신 프로젝트 '현대 호프 포 캔서' 출범

첸나이, 인도, 2025년 10월 15일 -- 인도 최고 교육기관인 인도공과대학 마드라스(IIT 마드라스)가 현대자동차 인도법인(HMIL)의 사회공헌 부문인 현대자동차 인도재단(Hyundai Motor India Foundation, HMIF)과 협력해 인도 소아암 치료의 혁신을 선도할 이니셔티브 '현대 호프 포 캔서(Hyundai Hope for Cancer)'를 출범했다. HMIF는 장기 사회공헌 활동의 일환으로 이번 프로젝트에 56크로르 규모의 사회공헌 투자를 진행했다. HMIL은 한국 완성차 제조사 현대자동차의 인도법인으로 이번 이니셔티브는 현대차의 글로벌 '호프 온 휠스(Hope on Wheels)' 프로그램과 맥을 같이하며, 전 세계 소아암 어린이를 계속 지원하겠다는 현대차의 의지를 보여준다. 이 이니셔티브의 핵심은 IIT 마드라스에 설립된 현대 암 유전체 센터(Hyundai Centre for Cancer Genomics)다. 이 센터는 의료진, 연구원, 제약 분야 전문가, 글로벌 파트너들이 협력하는 연구 허브로, 국제 암 유전체 컨소시엄(ICGC), 세계보건기구(WHO) 산하 국제 암연구소(
- 김갑성 기자
- 2025-10-15 16:18
워터스, '전하 검출 질량 분석 기술' 출시, 차세대 바이오 치료제 개발 가속

헤드라인 Xevo™ CDMS는 분자량이 크고 이질적인 생체분자에 대해 직접적이고 정확한 질량 검출을 지원. 1 검체당 10분 이내에 바이러스 벡터 캡시드 구분 (Empty, Partial, Full) 및 단백질 복합체, 핵산, 유전자 전달체를 정확하게 분석 가능.2 세포 및 핵산 분석 시, 기존 방법에 비해 최대 100배 적은 검체량으로도 분석 가능.3 밀포드, 매사추세츠주, 2025년 10월 15일 -- 워터스 코퍼레이션(Waters Corporation, NYSE: WAT)이 13일 차세대 치료제와 구조 생물학의 핵심인 광범위한 초대형 생체분자를 탁월하게 측정•특성화 분석할 수 있는 'Waters Xevo 전하 검출 질량 분석기(Charge Detection Mass Spectrometer, 이하 'CDMS')'를 공개했다. 세포 및 유전자 치료제, mRNA, 복합 단백질 치료제의 급속한 성장으로 과학자들은 점점 더 크고 이질적인 약물 치료제를 분석하는 데 상당한 어려움에 직면하고 있다. 하지만 기존의 분석 도구는 아주 작은 차이를 구별해낼 수 있는 능력인 분해능(resolution)뿐만 아니라
- 김갑성 기자
- 2025-10-15 15:20
Sinocare Showcases Its Comprehensive Diabetes Management Solutions at EASD

VIENNA, Oct. 15, 2025 -- The 61st Annual Meeting of the European Association for the Study of Diabetes (EASD 2025) was successfully held in Vienna, Austria. During the conference, Sinocare hosted an international industry symposium and an exclusive networking dinner, fully demonstrating the company's professional expertise in diabetes management. International Experts Applaud iCan CGM's Exceptional Clinical Performance On the opening Monday of EASD 2025 in Vienna, Professor Lori Laffel, Dr. Guido Freckmann, and Professor Julia Mader were invited to share their researches
- 김갑성 기자
- 2025-10-15 14:34

이전

21 22 23 24 25 26 27 28 29 30

많이 본 기사

최근기사

2025-11-04_TUE

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 11월 04일 19시 40분